Arjo AB (publ) (FRA:A39)

Market Cap	698.90M -25.3%
Revenue (ttm)	1.02B -2.6%
Net Income	30.86M -32.9%
EPS	0.11 -32.9%
Shares Out	n/a
PE Ratio	22.65
Forward PE	14.06
Dividend	0.09 (3.47%)
Ex-Dividend Date	Apr 30, 2025

Volume	n/a
Average Volume	110
Open	2.520
Previous Close	2.526
Day's Range	2.520 - 2.520
52-Week Range	2.412 - 3.562
Beta	n/a
RSI	40.23
Earnings Date	Jan 30, 2026

About Arjo AB

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobili...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1957
• Employees: 7,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A39

Financial Performance

In 2025, Arjo AB's revenue was 11.00 billion, a decrease of -2.59% compared to the previous year's 11.29 billion. Earnings were 334.00 million, a decrease of -32.93%.

Financial numbers in SEK